Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02209545 · ClinicalTrials.gov registry record · Phase 4
Misoprostol for Reduction of Blood Loss During Fibroid Surgery
A Phase 4 study, sponsored by Northwestern University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 47
- Enrollment target
NCT02209545 is a Phase 4 study that was terminated before completion, run by Northwestern University. The registered enrollment target is 47 participants.
The verdict
NCT02209545, a Phase 4 study, was terminated before completion, sponsored by Northwestern University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 47 participants
- Enrollment target
Study Summary
The aim of this research work is to assess the impact of a single preoperative dose of buccal misoprostol in reducing blood loss during abdominal fibroid surgery.
Interventions
- DRUG Placebo
- DRUG Misoprostol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2014-10 |
| Est. Completion | 2022-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02209545
The ClinicalTrials.gov registry entry for NCT02209545 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02209545 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02209545 about?
NCT02209545 is a clinical study titled "Misoprostol for Reduction of Blood Loss During Fibroid Surgery". The aim of this research work is to assess the impact of a single preoperative dose of buccal misoprostol in reducing blood loss during abdominal fibroid surgery.
What is the current status of trial NCT02209545?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 47 participants. The study started on 2014-10. Estimated completion is 2022-07.
What interventions are being tested in trial NCT02209545?
The interventions under investigation include: Placebo (DRUG), Misoprostol (DRUG).
Who is sponsoring clinical trial NCT02209545?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.